Vaccine-induced memory CD8+ T cells cannot prevent central nervous system virus reactivation

Journal of Immunology

Volumn 176, Issue 5, 2006, Pages 3062-3069

  Ramakrishna, Chandran ^a   Atkinson, Roscoe A ^b   Stohlman, Stephen A ^a,b,c   Bergmann, Cornelia C ^a,b,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD8 ANTIGEN; INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ANTIVIRAL ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORONAVIRUS; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; EFFECTOR CELL; IMMUNOREGULATION; IMMUNOSURVEILLANCE; IN VITRO STUDY; IN VIVO STUDY; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; TARGET CELL; VIRUS INHIBITION; VIRUS REACTIVATION;

EID: 33644551852     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.5.3062     Document Type: Article

References (53)

1. Tortorella, D., B. E. Gewurz, M. H. Furman, D. J. Schust, and H. L. Ploegh. 2000. Viral subversion of the immune system. Annu. Rev. Immunol. 18: 861-926.
2. Robinson, H. L., and R. R. Amara. 2005. T cell vaccines for microbial infections. Nat. Med. 11(4 Suppl.): S25-S32.
3. Shoukry, N. H., A. G. Cawthon, and C. M. Walker. 2004. Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu. Rev. Microbiol. 58: 391-424.
4. Chisari, F. V., and C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13: 29-60.
5. Borrow, P., and G. M. Shaw. 1998. Cytotoxic T-lymphocyte escape viral variants: how important are they in viral evasion of immune clearance in vivo? Immunol Rev. 164: 37-51.
6. Ciurea, A., L. Hunziker, R. M. Zinkemagel, and H. Hengartner. 2001. Viral escape from the neutralizing antibody response: the lymphocytic choriomeningitis virus model. Immunogenetics 53: 185-189.
7. Reignat, S., G. J. Webster, D. Brown, G. S. Ogg, A. King, S. L. Seneviratne, G. Dusheiko, R. Williams, M. K. Maini, and A. Bertoletti. 2002. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J. Exp. Med. 195: 1089-1101.
8. + T lymphocytes after infection with hepatitis C virus. J. Virol. 75: 5550-5558.
9. + T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192: 63-75.
10. Moskophidis, D., F. Lechner, H. Pircher, and R. M. Zinkemagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362: 758-761.
11. Griffin, D. E. 2003. Immune responses to RNA-virus infections of the CNS. Nat. Rev. Immunol. 3: 493-502.
12. Streilein, J. W. 1993. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr. Opin. Immunol. 5: 428-432.
13. González-Scarano, F., and J. Martín-García. 2005. The neuropathogenesis of AIDS. Nat. Rev. Immunol. 5: 69-81.
14. Schneider-Schaulies, J., V. T. Meulen, and S. Schneider-Schaulies. 2003. Measles infection of the central nervous system. J. Neurovirol 9: 247-252.
15. Mitchell, B. M., D. C. Bloom, R. J. Cohrs, D. H. Gilden, and P. G. E. Kennedy. 2003. Herpes simplex virus-1 and varicella-zoster virus latency in ganglia. J. Neurovirol. 9: 194-204.
16. Koralnik, I. J. 2002. Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy. J. Neurovirol. 8(Suppl. 2): 59-65.
17. McGayern, D. B., D. Homann, and M. B. A. Oldstone. 2002. T cells in the central nervous system: the delicate balance between viral clearance and disease. J. Infect. Dis. 186(Suppl. 2): S145-S151.
18. Schweighardt, B., and W. J. Atwood. 2001. Glial cells as targets of viral infection of the human nervous system. Prog. Brain Res. 132: 721-735.
19. Stohlman, S. A., C. C. Bergmann, and S. Perlman. 1999. Mouse hepatitis virus. In Persistent Viral Infections. R. Ahmed and I. Chen, eds. Wiley, New York, pp. 537-557.
20. Marten, N. W., S. A. Stohlman, and C. C. Bergmann. 2001. MHV infection of the CNS: mechanisms of immune mediated control. Viral Immunol. 14: 1-18.
21. Bergmann, C. C., B. Parra, D. R. Hinton, R. Chandran, M. Morrison, and S. A. Stohlman. 2003. Perforin-mediated effector function within the central nervous system requires IFN-γ mediated MHC up-regulation. J. Immunol. 170: 3204-3213.
22. Ramakrishna, C., S. A. Stohlman, R. D. Atkinson, M. J. Shlomchik, and C. C. Bergmann. 2002. Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells. J. Immunol. 168: 1204-1211.
23. Lin, M. T., D. R. Hinton, N. W. Marten, C. C. Bergmann, and S. A. Stohlman. 1999. Antibody prevents virus reactivation within the central nervous system. J. Immunol. 162: 7358-7368.
24. Bergmann, C. C., E. Dimacali, S. Stohl, W. Wei, M. M. C. Lai, S. Tahara, N. Marten, and S. A. Stohlman. 1998. Variability of persisting MHV RNA sequences constituting immune and replication relevant domains. Virology 244: 563-572.
25. + T cells in the central nervous system. J. Immunol. 173: 6265-6273.
26. Hawke, S., P. G. Stevenson, S. Freeman, and C. R. M. Bangham. 1998. Long term persistence of activated cytotoxic T lymphocytes after viral infection of the central nervous system. J. Exp. Med. 187: 1575-1582.
27. Fleming, J. O., M. Trousdale, F. El-Zaatari, S. A. Stohlman, and L. P. Weiner. 1986. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J. Virol. 58: 869-876.
28. González, J. M., C. C. Bergmann, B. Fuss, D. R. Hinton, C. Kangas, W. B. Macklin, and S. A. Stohlman. 2005. Expression of a dominant negative IFN-γ receptor on mouse oligodendrocytes. Glia 51: 22-34.
29. + T cells during viral persistence in the central nervous system. J. Immunol. 163: 3379-3387.
30. + T cells in primary and secondary influenza pneumonia. Immunity 8: 683-691.
31. Ostler, T., T. Hussell, C. D. Surh, P. Openshaw, and S. Ehl. 2001. Long-term persistence and reactivation of T cell memory in the lung of mice infected with respiratory syncytial virus. Eur. J. Immunol. 31: 2574-2582.
32. Chen, A. M., N. Khanna, S. A. Stohlman, and C. C. Bergmann. 2005. Virus-specific and bystander CD8 T cells recruited during virus-induced encephalomyelitis. J. Virol. 79: 4700-4708.
33. McNally, J. M., and R. M. Welsh. 2002. Bystander T cell activation and attrition. Curr. Top. Microbiol. Immunol. 263: 29-41.
34. McGavern, D. B., and P. Truong. 2004. Rebuilding an immune-mediated central nervous system disease: weighing the pathogenicity of antigen-specific versus bystander T cells. J. Immunol. 173: 4779-4790.
35. + T cells undergoing primary and secondary responses to infection in the same host. J. Immunol. 170: 4933-4942.
36. Shen, H., J. K. Whitmire, X. Fan, D. J. Shedlock, S. M. Kaech, and R. Ahmed. 2003. A specific role for B cells in the generation of CD8 T cell memory by recombinant Listeria monocytogenes. J. Immunol. 170: 1443-1451.
37. Früh, K., and Y. Yang. 1999. Antigen presentation by MHC class I and its regulation by interferon γ. Curr. Opin. Immunol. 11: 76-81.
38. Sedgwick, J. D., and W. F. Hickey. 1997. Antigen presentation in the central nervous system. In Immunology of the Central Nervous System. R. W. Keane and W. F. Hickey, eds. Oxford University Press, Oxford, pp. 364-418.
39. + T cells. Nature 401: 76-79.
40. Redwine, J. M., M. J. Buchmeier, and C. F. Evans. 2001. In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection. Am. J. Pathol. 159: 1219-1224.
41. Bergmann, C. C., B. Parra, D. R. Hinton, C. Ramakrishna, K. C. Dowdell, and S. A. Stohlman. 2004. Perform and γ interferon-mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cells. J. Virol. 78: 1739-1750.
42. + T cells during primary and secondary viral infections. J. Immunol. 174: 5936-5940.
43. Stohlman, S. A., and D. R. Hinton. 2001. Viral induced demyelination. Brain Pathol. 11: 92-106.
44. Bachmann, M. F., and R. M. Zinkernagel. 1997. Neutralizing antiviral B cell responses. Annu. Rev. Immunol. 15: 235-270.
45. Wong, P., and E. G. Pamer. 2003. CD8 T cell responses to infectious pathogens. Annu. Rev. Immunol. 21: 29-70.
46. Kaech, S. M., E. J. Wherry, and R. Ahmed. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2: 251-262.
47. Kägi, D., F. Vignaux, B. Ledermann, K. Bürki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265: 528-530.
48. Walzer, T., A. Marcais, F. Saltel, C. Bella, P. Jurdic, and J. Marvel. 2003. Cutting edge: immediate RANTES secretion by resting memory CD8 T cells following Ag stimulation. J. Immunol. 170: 1615-1619.
49. Cook, D. N., O. Smithies, R. M. Stricter, J. A. Frelinger, and J. S. Serody. 1999. CD8 T cells are a biologically relevant source of macrophage inflammatory protein-1α in vivo. J. Immunol. 162: 5423-5428.
50. + T cells: potential roles in inflammation. J. Immunol. 158: 3046-3053.
51. Olson, J. K., J. Ludovic-Croxford, and S. D. Miller. 2004. Innate and adaptive immune requirements for induction of autoimmune demyelinating disease by molecular mimicry. Mol. Immunol. 40: 1103-1108.
52. Dai, Z., I. W. Nasr, M. Reel, S. Deng, L. Diggs, C. P. Larsen, D. M. Rothstein, and F. G. Lakkis. 2005. Impaired recall of CD8 memory T cells in immunologically privileged tissue. J. Immunol. 174: 1165-1170.
53. Pewe, L., G. F. Wu, E. M. Barnett, R. F. Castro, and S. Perlman. 1996. Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease. Immunity 5: 253-262.